October 7, 1997Circulation
Effect of Serotonin, Thromboxane A₂, and Specific Receptor Antagonists on Vascular Smooth Muscle Cell Proliferation
Why the study?
Do serotonin and thromboxane A2 synergistically induce vascular smooth muscle cell proliferation, and can specific antagonists block this effect?
Population
Canine aortic smooth muscle cells (SMCs)
Comparison
Serotonin and thromboxane A2, alone or in… vs Vehicle/control or individual treatments
Design
Preclinical
Authors
Discussion
Loading...
Member takes
Implication
May warrant testing combined 5-HT2/TXA2 antagonism to limit restenosis; leaves open translation from animal models to clinical trials.
Key Points
- To examine whether serotonin and thromboxane A2 induce vascular smooth muscle cell proliferation independently or synergistically, and whether dual receptor blockade can suppress this response.
- Cultured canine aortic smooth muscle cells in serum-free medium and treated them with serotonin, the stable thromboxane A2 mimetic U46619, or both.
- Quantified cellular proliferation and mitogenic activity using [3H]thymidine DNA incorporation assays and direct cell counting.
- Assessed inhibition of proliferation using the 5-HT2 receptor antagonist LY281067 and the thromboxane A2 synthase inhibitor/receptor antagonist ridogrel individually and combined.
- Serotonin and the thromboxane A2 mimetic each independently stimulated smooth muscle cell proliferation at concentrations of 100 nmol/L.
- Co-administration of serotonin and thromboxane A2 exerted a synergistic mitogenic effect on smooth muscle cell proliferation, even at subthreshold concentrations.
- LY281067 and ridogrel selectively blocked the proliferation induced by serotonin and thromboxane A2, respectively, while combined antagonist administration abolished all mitogenic activity.
Structured PICO
Do serotonin and thromboxane A2 synergistically induce vascular smooth muscle cell proliferation, and can specific antagonists block this effect?
P
Population
Canine aortic smooth muscle cells (SMCs)
I
Intervention
Serotonin (5-HT) and thromboxane A2 (TXA2) (U46619), alone or in combination, with or without 5-HT2 receptor antagonist (LY281067) and TXA2 synthase inhibitor/receptor antagonist (ridogrel)
C
Comparator
Vehicle/control or individual treatments
O
Outcome
Smooth muscle cell proliferation (measured by [3H]thymidine incorporation into DNA and cell counting)surrogate
Serotonin and thromboxane A2 synergistically promote vascular smooth muscle cell proliferation, suggesting that combined receptor antagonism may help attenuate restenosis after angioplasty.
Cite This Study
Pakala et al. (1997) studied this question.